Format

Send to

Choose Destination
Open Forum Infect Dis. 2015 Jun 5;2(2):ofv079. doi: 10.1093/ofid/ofv079. eCollection 2015 Apr.

CD4 Response Up to 5 Years After Combination Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients in Latin America and the Caribbean.

Author information

1
Fundação Oswaldo Cruz , Instituto de Nacional de Infectologia Evandro Chagas , Rio de Janeiro , Brazil.
2
Department of Infectious Diseases , Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán.
3
Instituto de Medicina Tropical Alexander von Humboldt , Universidad Peruana Cayetano Heredia , Lima , Peru.
4
Vanderbilt University School of Medicine , Nashville, Tennessee.
5
Division of Infectious Diseases, Department of Medicine , Weill Cornell Medical College , New York.
6
School of Medicine , University of Chile , Santiago.
7
Universidad Nacional Autónoma de Honduras , Tegucigalpa.
8
Fundación Huesped , Buenos Aires , Argentina.

Abstract

We describe CD4 counts at 6-month intervals for 5 years after combination antiretroviral therapy initiation among 12 879 antiretroviral-naive human immunodeficiency virus-infected adults from Latin America and the Caribbean. Median CD4 counts increased from 154 cells/mm(3) at baseline (interquartile range [IQR], 60-251) to 413 cells/mm(3) (IQR, 234-598) by year 5.

KEYWORDS:

HIV/AIDS; Latin America and the Caribbean; cART; cohort; combination antiretroviral therapy; immune recovery; inverse probability of censoring weights

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center